참고문헌
- Ademuyiwa F, Groman A, O'Connor T, et al (2011). Impact of body mass index on clinical outcomes in triple-negative breast cancer. Cancer, 117, 4132-40. https://doi.org/10.1002/cncr.26019
- Alegre MM, Knowles MH, Robison RA, O'Neill KL (2013). Mechanics behind breast cancer prevention-focus on obesity, exercise and dietary fat. Asian Pac J Cancer Prev, 14, 2207-12. https://doi.org/10.7314/APJCP.2013.14.4.2207
- Berclaz G, Li S, Price KN, et al (2004). Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol, 15, 875-84. https://doi.org/10.1093/annonc/mdh222
- de Azambuja E, McCaskill-Stevens W, Francis P, et al (2010). The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial. Breast Cancer Res Treat, 119, 145-53. https://doi.org/10.1007/s10549-009-0512-0
- Engin H, Bilir C, Tekin IO (2013). Prognostic significance of peripheral blood flow cytometry parameters in patients with non-metastatic breast cancer.. Asian Pac J Cancer Prev, 14, 7645-9. https://doi.org/10.7314/APJCP.2013.14.12.7645
- Ewertz M, Jensen MB, Gunnarsdottir KA, et al (2011). Effect of obesity on prognosis after early stage breast cancer. J Clin Oncol, 29, 25-31. https://doi.org/10.1200/JCO.2010.29.7614
- Goodwin P (2013). Obesity and endocrine therapy: Host factors and breast cancer outcome. The Breast, 22, 44-7. https://doi.org/10.1016/j.breast.2012.03.009
- Griggs JJ, Sorbero ME, Lyman GH (2005). Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med, 165, 1267-73. https://doi.org/10.1001/archinte.165.11.1267
- Klimant E, Glurich I, Mukesh B, Onitilo A (2011). Blood type, hormone receptor status, HER2/neu status, and survival in breast cancer: A retrospective study exploring relationships in a phenotypically well-defined cohort. Clin Med & Res, 9, 111-8. https://doi.org/10.3121/cmr.2011.907
- Ladoire S, Dalban C, Roche H, et al (2014). Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: A pooled analysis of two randomised trials. Eur J Cancer, 50, 506-16. https://doi.org/10.1016/j.ejca.2013.11.013
- Malcolm AM, Yasantha A, Farhana B, et al (2009). Cancer epidemiology in South Asia - past, present and future. Asian Pac J Cancer Prev, 10, 49-67.
- Olmez OF, Evrensel T, Cubukcu E, et al (2013). Prognostic significance of human epidermal receptor (HER)- 3 immunohistochemical expression in patients with metastatic breast cancer. Asian Pac J Cancer Prev, 14, 4115-9. https://doi.org/10.7314/APJCP.2013.14.7.4115
- Parekh N, Chandran U, Bandera EV (2012). Obesity in cancer survival. Annu Rev Nutr, 32, 311-42. https://doi.org/10.1146/annurev-nutr-071811-150713
- Petrelli JM, Calle EE, Rodriquez C, Thun MJ (2002). Body mass index, height and postemenapausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control, 13, 325-32. https://doi.org/10.1023/A:1015288615472
- Protani M, Coory M, Martin JH (2010). Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat, 123, 627-35. https://doi.org/10.1007/s10549-010-0990-0
- Ryu SY, Kim CB, Nam CM, et al (2001). Is body mass index the prognostic factor in breast cancer? a meta-analysis. J Korean Med Sci, 16, 610-4. https://doi.org/10.3346/jkms.2001.16.5.610
- Sestak I, Distler W, Forbes JF, et al (2010). Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial. J Clin Oncol, 28, 3411-5. https://doi.org/10.1200/JCO.2009.27.2021
- Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 283-98. https://doi.org/10.3322/caac.21153
- Suleeporn S, Arkom C, Pattama P, et al (2013). Obesity, diet and physical inactivity and risk of breast cancer in Thai women. Asian Pac J Cancer Prev, 14, 7023-7. https://doi.org/10.7314/APJCP.2013.14.11.7023
- Tanriverdi O, Meydan N, Barutca S (2014). Reconsideration of clinical and histopathological prognostic factors in breast cancer patients: a single center experience.. Asian Pac J Cancer Prev, 15, 807-12. https://doi.org/10.7314/APJCP.2014.15.2.807
- Wu LZ, Han RQ, Zhou JY, et al (2014). Incidence and mortality of breast cancer in Jiangsu, China. Asian Pac J Cancer Prev, 15, 2727-32. https://doi.org/10.7314/APJCP.2014.15.6.2727
- Taghavi A, Fazeli Z, Vahedi M, et al (2012). Incidence trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev, 13, 367-70. https://doi.org/10.7314/APJCP.2012.13.1.367
피인용 문헌
- Taxane-Based Regimens as Adjuvant Treatment for Breast Cancer: a Retrospective Study in Egyptian Cancer Patients vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.65